Weight Loss Supplement-Induced Pulmonary Hypertension: A Decades Delayed Presentation of Fenfluramine-Phentermine

Am J Ther. 2023 May 1;30(3):e300-e301. doi: 10.1097/MJT.0000000000001387.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fenfluramine / adverse effects
  • Humans
  • Hypertension, Pulmonary* / chemically induced
  • Hypertension, Pulmonary* / diagnosis
  • Hypertension, Pulmonary* / drug therapy
  • Obesity
  • Phentermine* / adverse effects
  • Weight Loss

Substances

  • Phentermine
  • Fenfluramine